JUN 30, 2026 · REGULATORY LABEL UPDATE
FDA supplemental approval: Remifentanil Hydrochloride (Labeling)
U.S. Food and Drug Administration
FDA supplemental approval of labeling changes for remifentanil hydrochloride; regulatory action does not contain clinical trial data or efficacy evidence.
Reported
Approval date2026-06-30
Submission typeSupplemental labeling